BLUE

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Next report

May 12 2026

EPS estimate

—

Revenue estimate

—

EPS beats

6 of last 12

EPS surprise

2022: 15.9%2023: 1788.9%2023: 156.8%2023: -0.21%2023: -0.52%2024: -1687.9%2024: -1451.0%2024: -15.3%2024: 14.8%2025: 8.9%2025: -13.7%
Aug 4 2022May 14 2025
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
May 14 2025($3.29)($3.74)-13.7%$39M$30M-22.6%
Mar 27 2025($6.15)($5.60)+8.9%$27M$25M-7.2%
Nov 14 2024($7.28)($6.20)+14.8%$18M$11M-41.2%
Aug 14 2024($7.28)($8.40)-15.3%$24M$16M-33.6%
May 9 2024($0.49)($7.60)-1451.0%$19M$19M-3.4%
Mar 26 2024($0.66)($11.80)-1687.9%$17M$8M-53.5%
Nov 7 2023($13.13)($13.20)-0.5%$14M$12M-8.6%
Aug 8 2023($13.37)($13.40)-0.2%$11M$7M-39.0%
May 9 2023($7.39)$4.20+156.8%$7M$2M-63.5%
Mar 29 2023($0.45)$7.60+1788.9%$1M$62000-94.1%
Nov 7 2022($1.12)($0.94)+15.9%$1M$71000-93.4%
Aug 4 2022($1.30)($1.27)+2.1%$824167$2M+84.3%

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev-32.35%
EPS—
FY2028
Rev+20.22%
EPS—
FY2029
Rev+24.62%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029E
Revenue Avg$409M$277M$333M$415M
Low$409M$277M$333M$415M
High$409M$277M$333M$415M
EBITDA Avg$23M$49M$113M$142M
Low$23M$49M$113M$142M
High$23M$49M$113M$142M
EBIT Avg$-68M$-51M$-30,174$11M
Low$-68M$-51M$-30,174$11M
High$-68M$-51M$-30,174$11M
Net Income Avg$-83M$-66M$-15M$-4M
Low$-83M$-66M$-15M$-4M
High$-83M$-66M$-15M$-4M
EPS Avg$-8.56$-6.86$-1.56$-0.46
Low$-8.56$-6.86$-1.56$-0.46
High$-8.56$-6.86$-1.56$-0.46
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 1
Quarterly
MetricQ4 2026
Revenue Avg$116M
Low$116M
High$116M
EBITDA Avg$58M
Low$58M
High$58M
EBIT Avg$34M
Low$34M
High$34M
Net Income Avg$22M
Low$22M
High$22M
EPS Avg$2.28
Low$2.28
High$2.28
Analysts (Rev / EPS)1 / 1
AI Earnings SummaryQ3 2024
Checking for summary...
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.